Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

Cytarabine或Cytosine arabinoside

Cytarabine injection, indicated for use with other cytostatics, is used to treat leukemia and lymphoma. Common dosage: – Induction of remission, consolidation and maintenance therapy for acute non-lymphocytic leukemia in adults and children – Induction of remission, consolidation and treatment for acute lymphocytic leukemia in adults and children – Intrathecal prevention and treatment of leukemia infiltration of the central nervous system. – Treatment of moderate and severe non-Hodgkin’s lymphoma in adults – Treatment of non-Hodgkin’s lymphoma in children – Treatment of blast crisis in chronic myeloid leukemia High-dose therapy: – Non-Hodgkin’s lymphoma resistant to other agents – Acute non-Hodgkin’s lymphoma resistant to other agents – Acute lymphoblastic leukemia resistant to other agents – Relapse of acute leukemia – Leukemia due to special causes (leukemia secondary to previous chemotherapy and/or radiotherapy, leukemia transformed from preleukemia) – Consolidation treatment of patients under 60 years of age in remission from acute non-lymphocytic leukemia – Blastic crisis in chronic myeloid leukemia

Share:

Featured products

Laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor.